Skip to content
Research Article Open access CC BY 4.0

Understanding Complement-mediated Nervous System aging in Order to Develop Neurodegenerative Therapeutics

Gabriel Pisani, Byron Baron

International Blood Research & Reviews · pp. 42–52 · Published 2 Aug 2022

10.9734/ibrr/2022/v13i430185

Abstract

Aging is becoming one of the biggest burdens to the developed world, mainly due to it being linked to a variety of diseases from neurodegenerative disorders such as Alzheimer’s disease to cancer. It involves the dysregulation of virtually every biological process known, affecting every organ and tissue by distinct mechanisms, the nature of which is only now beginning to be truly understood. This is also true for memory loss, which is considered one of the most typical signs of old age. This is not surprising, given the still limited knowledge regarding how memories and thoughts are stored and utilised by the Central Nervous System (CNS). A potential hint, however, is the recent discovery that the complement system plays a role in synaptic pruning, which is essential for erasing unneeded memories. This is particularly intriguing given that the complement system is a branch of the innate immune system which has been documented as being overactive with aging. This review will thus cover what is currently known about the relationship between the immune system and aging and how the changes in the immune system with age affect the brain in an effort to direct further research. This topic has not been reviewed as a whole, which is why this paper aims to summarise the information on this topic whilst also elaborating on the gaps in research in order to develop potential therapies for neurodegeneration and immunosenescence.

Inflammaging complement neuronal aging immunosenescence synaptic pruning microglia and astrocytes

References (67)

  1. 1 Inflamm‐aging: An Evolutionary Perspective on Immunosenescence [DOI]
  2. 2 Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages [DOI]
  3. 3 Complement Factor H Polymorphism in Age-Related Macular Degeneration [DOI]
  4. 4 Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner [DOI]
  5. 5 The Classical Complement Cascade Mediates CNS Synapse Elimination [DOI]
  6. 6 C-reactive Protein [DOI]
  7. 7 Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging [DOI]
  8. 8 The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease [DOI]
  9. 9 Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
  10. 10 Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain [DOI]
  11. 11 Age and Cancer Risk [DOI]
  12. 12 NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s Disease [DOI]
  13. 13 Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging [DOI]
  14. 14 Complement in disease: a defence system turning offensive [DOI]
  15. 15 Microglia during development and aging [DOI]
  16. 16 Age‐related alterations in the dynamic behavior of microglia [DOI]
  17. 17 Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study [DOI]
  18. 18 Reversing T-cell Dysfunction and Exhaustion in Cancer [DOI]
  19. 19 Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity [DOI]
  20. 20 ComplementC3-Deficient Mice Fail to Display Age-Related Hippocampal Decline [DOI]
  21. 21 Complement activation, regulation, and molecular basis for complement‐related diseases [DOI]
  22. 22 Naive T Cell Maintenance and Function in Human Aging [DOI]
  23. 23 Enhanced synaptic connectivity and epilepsy in C1q knockout mice [DOI]
  24. 24 Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease [DOI]
  25. 25 Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes [DOI]
  26. 26 The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation [DOI]
  27. 27 The alternative complement pathway revisited [DOI]
  28. 28 Advanced Age Impairs Macrophage Polarization [DOI]
  29. 29 Classical MHCI Molecules Regulate Retinogeniculate Refinement and Limit Ocular Dominance Plasticity [DOI]
  30. 30 NF-κB functions in the nervous system: From development to disease [DOI]
  31. 31 Immune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised [DOI]
  32. 32 Essential role of Mannose-binding lectin-associated serine protease-1 in activation of the complement factor D [DOI]
  33. 33 The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System [DOI]
  34. 34 From inflamm-aging to immune-paralysis: a slippery slope during aging for immune-adaptation [DOI]
  35. 35 Microglial degeneration in the aging brain - bad news for neurons? [DOI]
  36. 36 Functional Anatomy of Complement Factor H [DOI]
  37. 37 The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification [DOI]
  38. 38 Ficolins in complement activation [DOI]
  39. 39 Microglia in the Outer Retina and Their Relevance to Pathogenesis of Age-Related Macular Degeneration [DOI]
  40. 40 C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice [DOI]
  41. 41 Sublytic C5b‐9 induces IL‐6 and TGF‐β1 production by glomerular mesangial cells in rat Thy‐1 nephritis through p300‐mediated C/EBPβ acetylation [DOI]
  42. 42 Gene Expression Profiling of Human Neural Progenitor Cells Following the Serum-Induced Astrocyte Differentiation [DOI]
  43. 43 Look who is weaving the neural web: glial control of synapse formation [DOI]
  44. 44 Novel roles of complement in renal diseases and their therapeutic consequences [DOI]
  45. 45 The Role of MASP-1/3 in Complement Activation [DOI]
  46. 46 C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells [DOI]
  47. 47 Mechanisms of Signal Transduction Activated by Sublytic Assembly of Terminal Complement Complexes on Nucleated Cells [DOI]
  48. 48 Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease [DOI]
  49. 49 Replicative Senescence: The Final Stage of Memory T Cell Differentiation? [DOI]
  50. 50 Heterogeneity of MBL–MASP complexes [DOI]
  51. 51 Senolytics improve physical function and increase lifespan in old age [DOI]
  52. 52 Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? [DOI]
  53. 53 Senescent cell clearance by the immune system: Emerging therapeutic opportunities [DOI]
  54. 54 Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects [DOI]
  55. 55 Astrocyte morphology: Diversity, plasticity, and role in neurological diseases [DOI]
  56. 56 Context-dependent roles of complement in cancer [DOI]
  57. 57 Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID‐19 patients in Michigan, United States [DOI]
  58. 58 Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease [DOI]
  59. 59 Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging [DOI]
  60. 60 Immune checkpoint inhibitors and elderly people: A review [DOI]
  61. 61 Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment [DOI]
  62. 62 Blood-brain barrier (BBB) and the complement landscape [DOI]
  63. 63 Immune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised [DOI]
  64. 64 Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway [DOI]
  65. 65 Cellular Senescence and Lung Function during Aging. Yin and Yang [DOI]
  66. 66 Function and mechanisms of memory destabilization and reconsolidation after retrieval [DOI]
  67. 67 Protective Effects of Complement Component 8 Gamma Against Blood-Brain Barrier Breakdown [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

32

Page views

0

PDF downloads

5

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.